Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.135 USD | +6.76% | +11.15% | +18.59% |
May. 02 | Transcript : Puma Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Puma Biotechnology, Inc. Provides Earnings Guidance for the Second Quarter of Full Year of 2024 | CI |
Financials (USD)
Sales 2024 * | 219M | Sales 2025 * | 225M | Capitalization | 248M |
---|---|---|---|---|---|
Net income 2024 * | 10M | Net income 2025 * | 15M | EV / Sales 2024 * | 1.13 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.1 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
21.1
x | Employees | 185 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.6% |
Latest transcript on Puma Biotechnology, Inc.
1 day | +6.76% | ||
1 week | +11.15% | ||
Current month | +1.28% | ||
1 month | -2.56% | ||
3 months | -17.31% | ||
6 months | +35.13% | ||
Current year | +18.59% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 5.135 | +6.76% | 321,432 |
24-05-10 | 4.81 | +0.42% | 232,747 |
24-05-09 | 4.79 | -0.83% | 268,237 |
24-05-08 | 4.83 | +1.68% | 261,433 |
24-05-07 | 4.75 | +2.81% | 338,520 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.59% | 232M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- PBYI Stock